Delivery Order SPE2DB20D3104-SPE2DB25FV9K1
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,308.60 for Zepbound 10 mg/0.5 ml pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of the injectable diabetes medication under the DLA's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,596.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen (0.5 mL) on July 28, 2025. This is a firm fixed price, non-set-aside delivery order that will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The contract represents a single delivery of this diabetes treatment medication to support federal medical procurement needs. This delivery order falls...
- The Defense Logistics Agency awarded a $5,514.02 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999 ceiling value and extends through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,507.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract represents a small-value delivery order for the diabetes and weight management medication under the company's larger pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,875.36 for Zepbound 10 mg/0.5 ml pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract, executed without a set-aside designation, represents a competitive award to the pharmaceutical distributor for diabetes medication supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,500.82 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens on July 30, 2025. This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 31, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the supply of a diabetes and weight management...
- The Defense Logistics Agency awarded a delivery order valued at $5,339.27 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 1, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $6,208.02. This firm fixed-price delivery order is a non-set-aside award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...